Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Cartesian Therapeutics (RNAC) over the last 11 years, with Q3 2025 value amounting to -$10000.0.

  • Cartesian Therapeutics' Exchange Rate Effect rose 3333.33% to -$10000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $19000.0, marking a year-over-year increase of 9000.0%. This contributed to the annual value of -$21000.0 for FY2024, which is 6037.74% up from last year.
  • Cartesian Therapeutics' Exchange Rate Effect amounted to -$10000.0 in Q3 2025, which was up 3333.33% from $12000.0 recorded in Q2 2025.
  • Cartesian Therapeutics' 5-year Exchange Rate Effect high stood at $115000.0 for Q2 2022, and its period low was -$45000.0 during Q4 2022.
  • Moreover, its 5-year median value for Exchange Rate Effect was -$7000.0 (2021), whereas its average is -$1210.5.
  • As far as peak fluctuations go, Cartesian Therapeutics' Exchange Rate Effect crashed by 65000.0% in 2022, and later soared by 74000.0% in 2025.
  • Cartesian Therapeutics' Exchange Rate Effect (Quarter) stood at -$6000.0 in 2021, then crashed by 650.0% to -$45000.0 in 2022, then surged by 135.56% to $16000.0 in 2023, then tumbled by 193.75% to -$15000.0 in 2024, then surged by 33.33% to -$10000.0 in 2025.
  • Its last three reported values are -$10000.0 in Q3 2025, $12000.0 for Q2 2025, and $32000.0 during Q1 2025.